Edition:
United States

Insider Trading: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

274.82USD
24 Mar 2017
Change (% chg)

$-0.59 (-0.21%)
Prev Close
$275.41
Open
$277.08
Day's High
$278.10
Day's Low
$272.87
Volume
1,368,217
Avg. Vol
1,774,813
52-wk High
$333.65
52-wk Low
$223.02

All Insider Trades
Trading Date Name Title Type Shares Traded Price
12 Mar 2017

Clancy (Paul J)

Chief Financial Officer Sell 9,891 $291.55
28 Feb 2017

McKenzie (Paul Ph.D.)

Officer Sell 157 $293.26
28 Feb 2017

Sandrock Alfred W Jr

Officer Sell 973 $290.07
28 Feb 2017

McKenzie (Paul Ph.D.)

Officer Buy 481 $0.00
28 Feb 2017

McKenzie (Paul Ph.D.)

Officer Buy 2,730 $0.00
27 Feb 2017

Sandrock Alfred W Jr

Officer Buy 815 $0.00
27 Feb 2017

Alexander (Susan H)

Officer Buy 1,375 $0.00
27 Feb 2017

Alexander (Susan H)

Officer Buy 1,259 $0.00
27 Feb 2017

DiPietro (Kenneth Amadeo)

Officer Sell 1,083 $274.76
27 Feb 2017

Sandrock Alfred W Jr

Officer Sell 727 $274.76
27 Feb 2017

Sandrock Alfred W Jr

Officer Sell 296 $274.60
27 Feb 2017

Clancy (Paul J)

Chief Financial Officer Buy 663 $0.00
27 Feb 2017

Alexander (Susan H)

Officer Buy 728 $0.00
27 Feb 2017

Covino (Gregory F)

Officer Sell 8 $274.76
27 Feb 2017

DiPietro (Kenneth Amadeo)

Officer Sell 553 $274.76
27 Feb 2017

Alexander (Susan H)

Officer Sell 335 $284.75
27 Feb 2017

Sandrock Alfred W Jr

Officer Buy 628 $0.00
27 Feb 2017

Karaboutis (Adriana)

Officer Buy 1,494 $0.00
27 Feb 2017

Clancy (Paul J)

Chief Financial Officer Buy 2,873 $0.00
27 Feb 2017

Clancy (Paul J)

Chief Financial Officer Sell 1,352 $274.76
27 Feb 2017

Karaboutis (Adriana)

Officer Sell 253 $284.75
27 Feb 2017

Covino (Gregory F)

Officer Sell 25 $284.75
27 Feb 2017

Sandrock Alfred W Jr

Officer Buy 1,569 $0.00
27 Feb 2017

DiPietro (Kenneth Amadeo)

Officer Buy 2,300 $0.00
27 Feb 2017

Sandrock Alfred W Jr

Officer Buy 1,375 $0.00

Institutional Holders

% Shares Owned: 89.43%
# of Holders: 1,442
Total Shares Held: 193,126,304
3 Mo. Net Change: -1,673,407
# New Positions: 128
# Closed Positions: 113
# Increased Positions: 569
# Reduced Positions: 596
# Net Buyers: -27

Officers & Directors

Name Age Since Current Position

Stelios Papadopoulos

67 2014 Independent Chairman of the Board

Michel Vounatsos

55 2017 Chief Executive Officer, Director

Paul Clancy

55 2007 Chief Financial Officer, Executive Vice President - Finance

Kenneth Di Pietro

58 2012 Executive Vice President - Human Resources

Susan Alexander

60 2011 Executive Vice President, Chief Legal Officer and Corporate Secretary

Michael Ehlers

48 2016 Executive Vice President, Head - Research and Development

Adriana Karaboutis

54 2014 Executive Vice President - Technology , Business Solutions and Corporate Affairs

Paul McKenzie

51 2016 Executive Vice President - Pharmaceutical Operations & Technology

Alfred Sandrock

59 2015 Executive Vice President - Neurology Discovery and Development and Chief Medical Officer

Gregory Covino

51 2012 Chief Accounting Officer, Vice President - Finance

Alexander Denner

46 2009 Independent Director

Caroline Dorsa

57 2010 Independent Director

Nancy Leaming

68 2008 Independent Director

Richard Mulligan

61 2009 Independent Director

Robert Pangia

65 1997 Independent Director

Brian Posner

54 2008 Independent Director

Eric Rowinsky

59 2010 Independent Director

Lynn Schenk

71 1995 Independent Director

Stephen Sherwin

67 2010 Independent Director